Robotic liver parenchymal transection with scissor hepatectomy versus parenchymal transection with sealing device

Robotic liver parenchymal transection with scissor hepatectomy versus parenchymal transection with sealing device - SNAP'N'SEAL

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00035290

Enrollment

172

Registered

2024-10-18

Start date

2024-10-28

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign and malignant liver lesions C78.7 C22

Interventions

Group 1: Parenchymal transection with scissor hepatectomy Group 2: Parenchymal transection with sealing device (VesselSealer or SynchroSeal)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patients undergoing robotic liver surgery for benign or malignant lesions - Written informed consent

Exclusion criteria

Exclusion criteria: - Pregnancy and lactation - ASA = 4 - Patients requiring vascular reconstruction and/or extrahepatic resections - Impaired mental state or language barrier - Suspected lack of compliance

Design outcomes

Primary

Measure	Time frame
Rate of parenchymal transection associated complications at 90 days after hepatectomy	—

Secondary

Measure	Time frame
Operating time, blood loss, transection time, need for perioperative blood transfusion, hospital stay, readmission rate, morbidity, mortality, quality of life	—

Countries

Germany

Contacts

Public ContactEmrullah Birgin

Universitätsklinikum Ulm

emrullah.birgin@uniklinik-ulm.de+49 731 5000

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026